NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

QIAGEN acquires remaining stake in NeuMoDx Molecular for $248m

By NS Healthcare Staff Writer 18 Sep 2020

QIAGEN initially acquired a 19.9% stake in NeuMoDx, along with the right to acquire the remaining stake at a purchase price of $234m

FDA approves expanded use of CINtec PLUS Cytology....

The CINtec PLUS Cytology is an advanced cytology test that leverages biomarker

RDIF, Dr. Reddy’s collaborate on Sputnik V vaccine....

RDIF will supply Dr. Reddy's with 100 million doses of potential Covid-19

Takeda opens new R&D manufacturing facility to expand....

The new manufacturing facility in Boston is designed to primarily focus on

Jardiance granted FDA Fast Track designation for improved....

The FDA designation enables development of Jardiance to prevent hospitalisation for heart

Pharmaceuticals

Merck agrees to acquire $1bn equity stake in Seattle Genetics
15 Sep 20

Sanofi’s Dupixent gets FDA Breakthrough Therapy designation to treat EoE
15 Sep 20

QIAGEN acquires remaining stake in NeuMoDx Molecular for $248m

FDA approves expanded use of CINtec PLUS Cytology....

RDIF, Dr. Reddy’s collaborate on Sputnik V vaccine....

Takeda opens new R&D manufacturing facility to expand....

Jardiance granted FDA Fast Track designation for improved....

Pharmaceuticals

Merck agrees to acquire $1bn equity stake in Seattle Genetics
15 Sep 20

Sanofi’s Dupixent gets FDA Breakthrough Therapy designation to treat EoE
15 Sep 20

Gilead Sciences to buy Immunomedics in $21bn deal
14 Sep 20

Patient Care

Roche gets FDA EUA for cobas SARS-CoV-2 and Influenza A/B test
07 Sep 20

Philips to buy medical device firm Intact Vascular for $275m
28 Aug 20

Abbott’s low-cost rapid Covid-19 antigen test gets FDA authorisation
27 Aug 20

Nutraceuticals

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal
01 Sep 20

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol
10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins
11 Jun 20

NS Healthcare is using cookies

Merck agrees to acquire $1bn equity stake in Seattle Genetics15 Sep 20

Sanofi’s Dupixent gets FDA Breakthrough Therapy designation to treat EoE15 Sep 20

Gilead Sciences to buy Immunomedics in $21bn deal14 Sep 20

Roche gets FDA EUA for cobas SARS-CoV-2 and Influenza A/B test 07 Sep 20

Philips to buy medical device firm Intact Vascular for $275m 28 Aug 20

Abbott’s low-cost rapid Covid-19 antigen test gets FDA authorisation 27 Aug 20

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal01 Sep 20

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins11 Jun 20

OUR TITLES

AstraZeneca resumes Covid-19 vaccine AZD1222 trials....14 Sep 20

Taking connected healthcare to ‘the next....15 Jun 20

UK needs better PPE stockpiles for....12 Jun 20

Fujifilm to invest $928m to expand....10 Jun 20

Takeda to sell European non-core assets....09 Sep 20

Grifols to acquire remaining stake in....08 Sep 20

Bristol Myers to acquire Forbius for....25 Aug 20

Takeda to divest consumer health care....25 Aug 20

Pfizer, BioNTech to begin Phase 2/3....08 Sep 20

Gilead inks license deal with Jounce....02 Sep 20

Engitix, Takeda collaborate to develop therapies....26 Aug 20

Sinovac, Bio Farma Indonesia collaborate on....26 Aug 20

Merck agrees to acquire $1bn equity stake in Seattle Genetics
15 Sep 20

Sanofi’s Dupixent gets FDA Breakthrough Therapy designation to treat EoE
15 Sep 20

Gilead Sciences to buy Immunomedics in $21bn deal
14 Sep 20

Roche gets FDA EUA for cobas SARS-CoV-2 and Influenza A/B test
07 Sep 20

Philips to buy medical device firm Intact Vascular for $275m
28 Aug 20

Abbott’s low-cost rapid Covid-19 antigen test gets FDA authorisation
27 Aug 20

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal
01 Sep 20

Evolva unveils positive results from RESHAW trial of Veri-te resveratrol
10 Jul 20

Nestlé Health Science agrees to purchase stake in Vital Proteins
11 Jun 20

AstraZeneca resumes Covid-19 vaccine AZD1222 trials....
14 Sep 20

Taking connected healthcare to ‘the next....
15 Jun 20

UK needs better PPE stockpiles for....
12 Jun 20

Fujifilm to invest $928m to expand....
10 Jun 20

Takeda to sell European non-core assets....
09 Sep 20

Grifols to acquire remaining stake in....
08 Sep 20

Bristol Myers to acquire Forbius for....
25 Aug 20

Takeda to divest consumer health care....
25 Aug 20

Pfizer, BioNTech to begin Phase 2/3....
08 Sep 20

Gilead inks license deal with Jounce....
02 Sep 20

Engitix, Takeda collaborate to develop therapies....
26 Aug 20

Sinovac, Bio Farma Indonesia collaborate on....
26 Aug 20